A biomarker study in long-lasting amnestic mild cognitive impairment

BACKGROUND: Mild cognitive impairment (MCI) is a heterogeneous syndrome resulting from Alzheimer’s disease (AD) as well as to non-AD and non-neurodegenerative conditions. A subset of patients with amnestic MCI (aMCI) present with an unusually long-lasting course, a slow rate of clinical neuropsychol...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Alzheimers Res Ther
Prif Awduron: Cerami, Chiara, Dodich, Alessandra, Iannaccone, Sandro, Magnani, Giuseppe, Santangelo, Roberto, Presotto, Luca, Marcone, Alessandra, Gianolli, Luigi, Cappa, Stefano F., Perani, Daniela
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2018
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5918759/
https://ncbi.nlm.nih.gov/pubmed/29695292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0369-8
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg